Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the combination of Dabrafenib and Trametinib compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of these medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific risks I should be aware of with this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain clinical trial (NCT02039947). Contact the study team or your healthcare provider for specific answers.

What this study is about